Better Therapeutics, Inc.

Better Therapeutics, Inc. (Nasdaq: BTTX) is a prescription digital therapeutics company focused on cardiometabolic diseases, including type 2 diabetes and hypertension. The company reached the public markets through a merger with Mountain Crest Acquisition Corp. II, a blank-check vehicle sponsored by Mountain Crest Capital LLC that completed its IPO in 2021. The business combination closed in October 2021, with shares trading under the BTTX ticker on Nasdaq. The company filed its quarterly report with the SEC on November 23, 2021, marking its first 10-Q as a publicly listed entity operating in the healthcare technology and digital therapeutics sector. Sign up at SpacDesk for full filing data, SPAC metrics, and deal history on BTTX and hundreds of other transactions.